Found 21 matching trials
The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study
N/AThe primary hypothesis is that titration of ACE inhibitor and Angiotensin R...
Location
University of Alabama at Birmingham
The GUARDIAN Pilot Trial
NAThe treatments will be: 1) norepinephrine or phenylephrine infusion to main...
Status
Active Not Recruiting
Location
China Japan Union Hospital of Jilin University
Pathophysiologic Hemodynamics After Primary Unilateral Total Hip Arthroplasty in Patients Receiving ACEIs and ARBs
N/AIncidence and pathophysiologic hemodynamics of postoperative orthostatic in...
Location
Hvidovre University Hospital
Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)
PHASE4The purpose of this study is to determine whether olmesartan medoxomil is e...
Location
Chinese PLA General Hospital
Asian Diabetes Outcomes Prevention Trial
PHASE4The aim of this study is to identify patients with DM at high risk of CVD u...
Location
Singapore General Hospital (SGH)
Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Risk of COVID_19
N/A1. To determine the risk of COVID -19 in patients who use ACEI and ARBS
2. ...
Location
Multiple Locations
Canagliflozin in Patients With Acute Decompansted Heart Failure
PHASE3The study aims to investigate the efficacy and safety of the early initiati...
Location
National heart institute
ACEi ARB Withdrawal in CKD Patients
NAThe American Heart Association guidelines for high blood pressure (BP) curr...
Location
University of California, San Francisco
Antihypertensive Medications and the Risk of Sepsis
N/AThe primary objective of this study was to assess whether there is an incre...
Location
Multiple Locations
ARB, ACEi, DRi Effects on COVID-19 Course Disease
N/AIt is supposed to monitor hypertensive patients who are infected or have cl...
Location
Medical Practice Prof D.Ivanov